Baltimore, MD - It is known that mesenchymal stem cells have veto-like properties. Essentially the veto cell inactivates, either through killing or induction of anergy, a cell that reacts against it. Theoretically, if the mesenchymal stem cells have veto-like properties, then this veto activity should be recognized in vivo by...
Duarte, CA - It is known that mesenchymal stem cells are potent immune modulators. The methods by which they inhibit various inflammatory reactions include production of immune suppressive cytokines such as IL-10, induction of tryptophan depletion using the enzyme IDO, and providing signal 1 in...
Bethesda, Maryland - The return of ex vivo expanded T cells into an "empty compartment" has been used successfully by Steven Rosenberg and various researchers at the NIH for treatment of cancer. Essentially the idea is that when T cells are placed into a compartment that is lymphodepleted, then the T cells will proliferate by homeostatic expansion and be able to...
Nagoya, Japan - Readers of StemCellPatents.com will be familiar with a previous publication stating that cord blood derived stem cells can accelerate reconstitution of hematopoietic stem cells. This concept of one type of stem cell helping other types of stem cells was demonstrated in a recent paper by Kajiguchi et al (Safety and...
Chicago, IL - The ability to use allogeneic cord blood transplants, without immune suppression is under great discussion. On the one hand, it is a fact that administration of allogeneic cord blood does not elicit GVHD when administered to non-immune suppressed patients (type "Bhattacharya N" and "cord blood" in pubmed for example papers). On the other hand...
Munster, Germany – The concept of immunological tolerance is paramount to stem cell therapeutic applications. Specifically, the ability to induce tolerance would allow for use of allogeneic stem cell therapeutics using "off-the shelf" cell lines that are well characterized and standardized for induction of specific biological activities. Tolerance induction is maintained by many...
We at StemCellPatents.com have been most fascinated by the first clinical report of using embryonic stem cell-derived products .
In response to our coverage of this event, the senior author of the paper, Dr. H.L. Trivedi has requested us to post the following:
" Thank you for your interest... Iowa City, Iowa USA
Due to the great interest generated by the first clinical use of embryonic stem cells we decided to see other papers in the area of immunological activities of embryonic stem cells.
The possibility that embryonic stem cells can be immune suppressive and therefore transplanted across... Gujarat, India -
To our knowledge the first-ever peer-reviewed publication describing clinical use of embryonic stem cells has appeared this week in the journal Transplantation Proceedings (Trivedi et al. Embryonic stem cell derived and adult hematopoietic stem cell transplantation for tolerance induction in a renal allograft recipient:-a case report.Transplant Proc...
Tolerogeneicity of Embryonic Stem Cells in Allogeneic animals
First Clinical Use of ES Cells